Received Feb 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | 7GF79 | — |
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | AMVA989A | — |
| MNQ | MENINGOCOCCAL CONJUGATE (MENACTRA) | SANOFI PASTEUR | 1 | — | — |
menveo was given to a patient by mistake; menveo was given to a patient by mistake; had Menactra first dose and received Menveo second dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 18-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number 7GF79, expiry date 31-DEC-2025) for prophylaxis. Co-suspect products included Men ACWY-CRM NVS (Menveo) (batch number AMVA989A) for prophylaxis and Meningococcal vaccine A/C/Y/W conj (dip tox) (Menactra) for prophylaxis. Concomitant products included HPV vaccine VLP rL1 4v (yeast) (Gardasil). On 08-JAN-2025, the patient received the 2nd dose of Menveo. On 27-NOV-2024, the patient received the 1st dose of Menveo. On 01-MAY-2023, the patient received the 1st dose of Menactra. On 27-NOV-2024, not applicable after receiving Menveo and an unknown time after receiving Menveo, the patient experienced interchange of vaccine products (Verbatim: had Menactra first dose and received Menveo second dose). On 08-JAN-2025, the patient experienced extra dose administered (Verbatim: menveo was given to a patient by mistake) and administered drug to incorrect patient (Verbatim: menveo was given to a patient by mistake). The outcome of the extra dose administered, administered drug to incorrect patient and interchange of vaccine products were unknown. Additional Information: GSK Receipt Date: 09-JAN-2025 The other health professional reported that a dose of Menveo was given to a patient by mistake, mentions patient looked similar to her sister who was supposed to be vaccinated with menveo, so the wrong patient got vaccinated which led to administered drug to incorrect patient. The patient also received gardasil vaccine on the same clinic day. The patient had Menactra first dose and the patient received Menveo dose (2 vials presentation) which led to interchange of vaccine products. 18 year old patient received 2 doses of Menveo which led to extra dose administered.
Gardasil